Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 253

1.

Infection risk with alemtuzumab decreases over time: pooled analysis of 6-year data from the CAMMS223, CARE-MS I, and CARE-MS II studies and the CAMMS03409 extension study.

Wray S, Havrdova E, Snydman DR, Arnold DL, Cohen JA, Coles AJ, Hartung HP, Selmaj KW, Weiner HL, Daizadeh N, Margolin DH, Chirieac MC, Compston DAS.

Mult Scler. 2018 Oct 5:1352458518796675. doi: 10.1177/1352458518796675. [Epub ahead of print]

PMID:
30289355
2.

Enhanced preservation of the human intestinal microbiota by ridinilazole, a novel Clostridium difficile-targeting antibacterial, compared to vancomycin.

Thorpe CM, Kane AV, Chang J, Tai A, Vickers RJ, Snydman DR.

PLoS One. 2018 Aug 2;13(8):e0199810. doi: 10.1371/journal.pone.0199810. eCollection 2018.

3.

Antimicrobial susceptibility and ribotypes of Clostridium difficile isolates from a Phase 2 clinical trial of ridinilazole (SMT19969) and vancomycin.

Snydman DR, McDermott LA, Thorpe CM, Chang J, Wick J, Walk ST, Vickers RJ.

J Antimicrob Chemother. 2018 Aug 1;73(8):2078-2084. doi: 10.1093/jac/dky135.

PMID:
29718329
4.

A repeat offender: Recurrent extraintestinal Clostridium difficile infection following fecal microbiota transplantation.

Gardiner BJ, Thorpe CM, Pinkham NV, McDermott LA, Walk ST, Snydman DR.

Anaerobe. 2018 Jun;51:68-72. doi: 10.1016/j.anaerobe.2018.04.007. Epub 2018 Apr 21.

PMID:
29709869
5.

Evaluation of a two-stage testing algorithm for the diagnosis of respiratory viral infections.

Gardiner BJ, Parker CEV, Rabson AR, Snydman DR, Doron S.

Diagn Microbiol Infect Dis. 2018 Aug;91(4):319-323. doi: 10.1016/j.diagmicrobio.2018.03.007. Epub 2018 Mar 12.

PMID:
29636246
6.

Absolute Lymphocyte Count: A Predictor of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients.

Gardiner BJ, Nierenberg NE, Chow JK, Ruthazer R, Kent DM, Snydman DR.

Clin Infect Dis. 2018 Oct 15;67(9):1395-1402. doi: 10.1093/cid/ciy295.

PMID:
29635432
7.

Evaluation of the In Vitro Activity of Eravacycline against a Broad Spectrum of Recent Clinical Anaerobic Isolates.

Snydman DR, McDermott LA, Jacobus NV, Kerstein K, Grossman TH, Sutcliffe JA.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e02206-17. doi: 10.1128/AAC.02206-17. Print 2018 May.

PMID:
29483114
8.

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation.

Marty FM, Ljungman P, Chemaly RF, Maertens J, Dadwal SS, Duarte RF, Haider S, Ullmann AJ, Katayama Y, Brown J, Mullane KM, Boeckh M, Blumberg EA, Einsele H, Snydman DR, Kanda Y, DiNubile MJ, Teal VL, Wan H, Murata Y, Kartsonis NA, Leavitt RY, Badshah C.

N Engl J Med. 2017 Dec 21;377(25):2433-2444. doi: 10.1056/NEJMoa1706640. Epub 2017 Dec 6.

9.

Role of Secondary Prophylaxis With Valganciclovir in the Prevention of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients.

Gardiner BJ, Chow JK, Price LL, Nierenberg NE, Kent DM, Snydman DR.

Clin Infect Dis. 2017 Nov 29;65(12):2000-2007. doi: 10.1093/cid/cix696.

PMID:
29020220
10.

Iron-related markers are associated with infection after liver transplantation.

Chow JKL, Ganz T, Ruthazer R, Simpson MA, Pomfret EA, Gordon FD, Westerman ME, Snydman DR.

Liver Transpl. 2017 Dec;23(12):1541-1552. doi: 10.1002/lt.24817.

PMID:
28703464
11.

Selective method for identification and quantification of Bifidobacterium animalis subspecies lactis BB-12 (BB-12) from the gastrointestinal tract of healthy volunteers ingesting a combination probiotic of BB-12 and Lactobacillus rhamnosus GG.

Poutsiaka DD, Mahoney IJ, McDermott LA, Stern LL, Thorpe CM, Kane AV, Baez-Giangreco C, McKinney J, Davidson LE, Leyva R, Goldin B, Snydman DR.

J Appl Microbiol. 2017 May;122(5):1321-1332. doi: 10.1111/jam.13436. Epub 2017 Apr 4.

PMID:
28256070
12.

Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients.

Ishida JH, Patel A, Mehta AK, Gatault P, McBride JM, Burgess T, Derby MA, Snydman DR, Emu B, Feierbach B, Fouts AE, Maia M, Deng R, Rosenberger CM, Gennaro LA, Striano NS, Liao XC, Tavel JA.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e01794-16. doi: 10.1128/AAC.01794-16. Print 2017 Feb.

13.

Trends in antimicrobial resistance among Bacteroides species and Parabacteroides species in the United States from 2010-2012 with comparison to 2008-2009.

Snydman DR, Jacobus NV, McDermott LA, Goldstein EJ, Harrell L, Jenkins SG, Newton D, Patel R, Hecht DW.

Anaerobe. 2017 Feb;43:21-26. doi: 10.1016/j.anaerobe.2016.11.003. Epub 2016 Nov 17.

PMID:
27867083
14.

Increasing Infectious Endocarditis Admissions Among Young People Who Inject Drugs.

Wurcel AG, Anderson JE, Chui KK, Skinner S, Knox TA, Snydman DR, Stopka TJ.

Open Forum Infect Dis. 2016 Jul 26;3(3):ofw157. eCollection 2016 Sep.

15.

In Vitro Evaluation of the Activity of Imipenem-Relebactam against 451 Recent Clinical Isolates of Bacteroides Group and Related Species.

Snydman DR, Jacobus NV, McDermott LA.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):6393-7. doi: 10.1128/AAC.01125-16. Print 2016 Oct.

16.

Differences in the Molecular Epidemiology and Antibiotic Susceptibility of Clostridium difficile Isolates in Pediatric and Adult Patients.

Kociolek LK, Gerding DN, Osmolski JR, Patel SJ, Snydman DR, McDermott LA, Hecht DW.

Antimicrob Agents Chemother. 2016 Jul 22;60(8):4896-900. doi: 10.1128/AAC.00714-16. Print 2016 Aug.

17.

Editorial Commentary: Chronic Lung Allograft Dysfunction in Lung Transplant Recipients: Another Piece of the Puzzle.

Gardiner BJ, Snydman DR.

Clin Infect Dis. 2016 Feb 1;62(3):320-2. doi: 10.1093/cid/civ877. Epub 2015 Nov 12. No abstract available.

PMID:
26565009
18.

Characteristics and outcomes of neutropenia after orthotopic liver transplantation.

Alraddadi B, Nierenberg NE, Price LL, Chow JK, Poutsiaka DD, Rohrer RJ, Cooper JT, Freeman RB, Snydman DR.

Liver Transpl. 2016 Feb;22(2):217-25. doi: 10.1002/lt.24332.

19.

Physician report cards and rankings yield long-lasting hand hygiene compliance exceeding 90%.

Reich JA, Goodstein ME, Callahan SE, Callahan KM, Crossley LW, Doron SI, Snydman DR, Nasraway SA Jr.

Crit Care. 2015 Aug 14;19:292. doi: 10.1186/s13054-015-1008-4.

20.

U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin.

Snydman DR, McDermott LA, Jacobus NV, Thorpe C, Stone S, Jenkins SG, Goldstein EJ, Patel R, Forbes BA, Mirrett S, Johnson S, Gerding DN.

Antimicrob Agents Chemother. 2015 Oct;59(10):6437-43. doi: 10.1128/AAC.00845-15. Epub 2015 Aug 3.

Supplemental Content

Loading ...
Support Center